首頁
Kindeva Drug Delivery L.P.

3月 2026Kindeva Drug Delivery L.P.的市場佔有率分析

Facilities with cutting-edge technology and high capacity for drug development and manufacturing. Explore our locations and discover their unique capabilities.

工作和職業 > 工作和就業

域名kindevadd.com

成立年份2020

僱員1001 - 5000

年度營收$200M - $500M

Kindeva Drug Delivery L.P.

Kindeva Drug Delivery L.P.（包含公司地區）

kindevadd.com

查看更多網站流量與參與度資訊

Kindeva Drug Delivery L.P.截至 3月 2026 的總收入為 200M - 500M

Kindeva Drug Delivery L.P. 熱門網域產生的總收入

Kindeva Drug Delivery L.P. 熱門網域 3 年內的總收入

Kindeva Drug Delivery L.P. 熱門網域的總收入

kindevadd.com200M - 500M

透過銷售情報查看更多內容

Kindeva Drug Delivery L.P.的熱門網域總造訪量

了解Kindeva Drug Delivery L.P.市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

kindevadd.com18.8K

透過銷售情報查看更多內容

Kindeva Drug Delivery L.P.的熱門網域平均造訪時長

分析Kindeva Drug Delivery L.P.參與度指標。

過去 3 個月平均造訪時長

子公司細目

kindevadd.com00:00:52

透過銷售情報查看更多內容

Kindeva Drug Delivery L.P.的熱門網域平均頁面瀏覽量

了解Kindeva Drug Delivery L.P.如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

kindevadd.com1.70

透過銷售情報查看更多內容

Kindeva Drug Delivery L.P.按網域劃分的熱門競爭對手

3月 2026的熱門類似網站，依相似度排名

aptar.com公司名Aptar僱員> 10001總部美國, 伊利諾伊州, Crystal Lake年度營收> $1B訪問總量86.7K商業服務和消費者服務 > 商業服務

使用的熱門技術Kindeva Drug Delivery L.P.

这些是Kindeva Drug Delivery L.P.顶级域名使用的行业网站技术

付費廣告 (10)

DoubleClick

市場行銷 (5)

Google Marketing Platform

轉換與分析 (4)

Google Analytics

小工具 (3)

Google Maps

更多技術

8

檢視所有

新聞與訊號來自Kindeva Drug Delivery L.P.

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞Kindeva Drug Delivery Company hires mike cowhig as chief legal officer.Kindeva appoints mike cowhig as chief legal officer.

新聞Kindeva Drug Delivery Company hires Dave.With a proven track record of successfully building and leading teams through significant growth and capacity expansion, Dave's appointment will ensure Kindeva continues to advance innovation and customer partnerships that improve patient outcomes.

新聞Kindeva Drug Delivery Company is developing AVERSA FENTANYL.The White House+1 The company noted ongoing concerns around transdermal fentanyl patch abuse and accidental pediatric exposure and said it is partnering with Kindeva to develop AVERSA(TM) FENTANYL, which combines Nutriband AVERSA(TM) abuse-deterrent technology with Kindeva FDA-approved fentanyl patch to deter abuse and reduce accidental exposure while maintaining access for patients who need prescription fentanyl products.